Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.

BACKGROUND: Stratified medicine aims to improve clinical and cost-effectiveness by identifying moderators of treatment that indicate differential response to treatment. Cognitive behavioural therapy (CBT) is often offered as a 'next-step' for patients who have not responded to antidepressa...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Button, K, Turner, N, Campbell, J, Kessler, D, Kuyken, W, Lewis, G, Peters, T, Thomas, L, Wiles, N
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: Elsevier 2014
_version_ 1826291934103076864
author Button, K
Turner, N
Campbell, J
Kessler, D
Kuyken, W
Lewis, G
Peters, T
Thomas, L
Wiles, N
author_facet Button, K
Turner, N
Campbell, J
Kessler, D
Kuyken, W
Lewis, G
Peters, T
Thomas, L
Wiles, N
author_sort Button, K
collection OXFORD
description BACKGROUND: Stratified medicine aims to improve clinical and cost-effectiveness by identifying moderators of treatment that indicate differential response to treatment. Cognitive behavioural therapy (CBT) is often offered as a 'next-step' for patients who have not responded to antidepressants, but no research has examined moderators of response to CBT in this population. We aimed, therefore, to identify moderators of response to CBT in treatment resistant depression. METHODS: We used linear regression to test for interactions between treatment effect and 14 putative moderator variables using data from the CoBalT randomised controlled trial. This trial examined the effectiveness of CBT given in addition to usual care (n=234) compared with usual care alone (n=235) for primary care patients with treatment resistant depression. RESULTS: Age was the only variable with evidence for effect modification (p Value for interaction term=0.012), with older patients benefiting the most from CBT. We found no evidence of effect modification by any other demographic, life, illness, personality trait, or cognitive variable (p≥0.2). CONCLUSIONS: Given the largely null findings, a stratified approach that might limit offering CBT is premature; CBT should be offered to all individuals where antidepressant medication has failed.
first_indexed 2024-03-07T03:06:57Z
format Journal article
id oxford-uuid:b2df0d14-bcc5-4fa7-9f64-2f7188f8ed3a
institution University of Oxford
language English
last_indexed 2024-03-07T03:06:57Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:b2df0d14-bcc5-4fa7-9f64-2f7188f8ed3a2022-03-27T04:14:49ZModerators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b2df0d14-bcc5-4fa7-9f64-2f7188f8ed3aEnglishSymplectic Elements at OxfordElsevier2014Button, KTurner, NCampbell, JKessler, DKuyken, WLewis, GPeters, TThomas, LWiles, NBACKGROUND: Stratified medicine aims to improve clinical and cost-effectiveness by identifying moderators of treatment that indicate differential response to treatment. Cognitive behavioural therapy (CBT) is often offered as a 'next-step' for patients who have not responded to antidepressants, but no research has examined moderators of response to CBT in this population. We aimed, therefore, to identify moderators of response to CBT in treatment resistant depression. METHODS: We used linear regression to test for interactions between treatment effect and 14 putative moderator variables using data from the CoBalT randomised controlled trial. This trial examined the effectiveness of CBT given in addition to usual care (n=234) compared with usual care alone (n=235) for primary care patients with treatment resistant depression. RESULTS: Age was the only variable with evidence for effect modification (p Value for interaction term=0.012), with older patients benefiting the most from CBT. We found no evidence of effect modification by any other demographic, life, illness, personality trait, or cognitive variable (p≥0.2). CONCLUSIONS: Given the largely null findings, a stratified approach that might limit offering CBT is premature; CBT should be offered to all individuals where antidepressant medication has failed.
spellingShingle Button, K
Turner, N
Campbell, J
Kessler, D
Kuyken, W
Lewis, G
Peters, T
Thomas, L
Wiles, N
Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title_full Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title_fullStr Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title_full_unstemmed Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title_short Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
title_sort moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care
work_keys_str_mv AT buttonk moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT turnern moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT campbellj moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT kesslerd moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT kuykenw moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT lewisg moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT peterst moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT thomasl moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare
AT wilesn moderatorsofresponsetocognitivebehaviouraltherapyasanadjuncttopharmacotherapyfortreatmentresistantdepressioninprimarycare